We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Interface
TILE
$2.19B
| $2.63M | 0.01% |
+158,823
| New | +$2.56M |
|
1052
Agnico Eagle Mines
AEM
$90.9B
| $2.62M | 0.01% |
+42,500
| New | +$2.47M |
|
|
SNCR
1053
DELISTED
Synchronoss Technologies
SNCR
| $2.61M | 0.01% |
60,993
+11,080
| +22% | +$492K |
|
|
CNR
1054
Core Natural Resources Inc
CNR
$4.67B
| $2.59M | 0.01% |
+178,632
| New | +$2.47M |
|
|
CHUY
1055
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.59M | 0.01% |
+99,917
| New | +$2.59M |
|
1056
LifeVantage
LFVN
$83.4M
| $2.59M | 0.01% |
165,827
-11,118
| -6% | -$163K |
|
1057
EPR Properties
EPR
$4.63B
| $2.58M | 0.01% |
+36,541
| New | +$2.7M |
|
|
ATSG
1058
DELISTED
Air Transport Services Group
ATSG
| $2.56M | 0.01% |
109,219
+52,831
| +94% | +$1.18M |
|
|
VIVO
1059
DELISTED
Meridian Bioscience Inc
VIVO
| $2.56M | 0.01% |
261,772
+39,150
| +18% | +$368K |
|
1060
Trimble
TRMB
$13.8B
| $2.54M | 0.01% |
61,013
-108,200
| -64% | -$4.3M |
|
1061
Bloom Energy
BE
$63.2B
| $2.54M | 0.01% |
+339,887
| New | +$1.65M |
|
|
REGI
1062
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.52M | 0.01% |
+93,650
| New | +$1.7M |
|
1063
Arcosa
ACA
$7.11B
| $2.51M | 0.01% |
56,435
+20,031
| +55% | +$770K |
|
1064
Community Health Systems
CYH
$412M
| $2.51M | 0.01% |
866,675
+455,575
| +111% | +$1.58M |
|
|
CCMP
1065
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.51M | 0.01% |
+17,400
| New | +$2.47M |
|
|
VRTV
1066
DELISTED
VERITIV CORPORATION
VRTV
| $2.5M | 0.01% |
127,058
+114,658
| +925% | +$2M |
|
1067
Mistras Group
MG
$502M
| $2.49M | 0.01% |
174,405
+61,961
| +55% | +$876K |
|
|
CLVS
1068
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.49M | 0.01% |
+238,503
| New | +$1.73M |
|
|
IPG
1069
DELISTED
Interpublic Group of Companies
IPG
| $2.47M | 0.01% |
+106,794
| New | +$2.35M |
|
|
APLS
1070
DELISTED
Apellis Pharmaceuticals
APLS
| $2.46M | 0.01% |
+80,491
| New | +$2.23M |
|
1071
Mattel
MAT
$4.2B
| $2.46M | 0.01% |
+181,466
| New | +$2.15M |
|
1072
Myers Industries
MYE
$1.24B
| $2.46M | 0.01% |
147,413
+80,498
| +120% | +$1.34M |
|
|
TPCO
1073
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $2.46M | 0.01% |
186,840
+31,588
| +20% | +$332K |
|
1074
iShares MSCI Taiwan ETF
EWT
$11B
| $2.46M | 0.01% |
+59,700
| New | +$2.35M |
|
1075
Cerence
CRNC
$399M
| $2.44M | 0.01% |
+108,041
| New | +$1.77M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.